151 related articles for article (PubMed ID: 28483521)
1. Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation.
Siqingaowa ; Sekar S; Gopalakrishnan V; Taghibiglou C
Biochem Biophys Res Commun; 2017 Jun; 488(1):136-140. PubMed ID: 28483521
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma.
Huang CM; Huang CS; Hsu TN; Huang MS; Fong IH; Lee WH; Liu SC
Cells; 2019 Dec; 9(1):. PubMed ID: 31861383
[No Abstract] [Full Text] [Related]
3. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
[TBL] [Abstract][Full Text] [Related]
4. SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism.
Sun Y; He W; Luo M; Zhou Y; Chang G; Ren W; Wu K; Li X; Shen J; Zhao X; Hu Y
Tumour Biol; 2015 Jun; 36(6):4133-41. PubMed ID: 25589463
[TBL] [Abstract][Full Text] [Related]
5. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer.
Zhou C; Qian W; Li J; Ma J; Chen X; Jiang Z; Cheng L; Duan W; Wang Z; Wu Z; Ma Q; Li X
J Exp Clin Cancer Res; 2019 Jul; 38(1):302. PubMed ID: 31296258
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
7. Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma.
Ma X; Zhao T; Yan H; Guo K; Liu Z; Wei L; Lu W; Qiu C; Jiang J
Cell Death Dis; 2021 May; 12(6):544. PubMed ID: 34039951
[TBL] [Abstract][Full Text] [Related]
8. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
[TBL] [Abstract][Full Text] [Related]
9. Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma.
Gao S; Shi Z; Li X; Li W; Wang Y; Liu Z; Jiang J
Oncol Rep; 2018 Apr; 39(4):1919-1929. PubMed ID: 29436682
[TBL] [Abstract][Full Text] [Related]
10. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
11. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
Kato S; Shirato K; Imaizumi K; Toyota H; Mizuguchi J; Odawara M; Che XF; Akiyama S; Abe A; Tomoda A
Oncol Rep; 2006 Apr; 15(4):843-8. PubMed ID: 16525669
[TBL] [Abstract][Full Text] [Related]
13. Effects of bovine fatty acid synthase, stearoyl-coenzyme A desaturase, sterol regulatory element-binding protein 1, and growth hormone gene polymorphisms on fatty acid composition and carcass traits in Japanese Black cattle.
Matsuhashi T; Maruyama S; Uemoto Y; Kobayashi N; Mannen H; Abe T; Sakaguchi S; Kobayashi E
J Anim Sci; 2011 Jan; 89(1):12-22. PubMed ID: 20852082
[TBL] [Abstract][Full Text] [Related]
14. Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism.
Yao L; Chen S; Li W
Arch Biochem Biophys; 2020 May; 684():108327. PubMed ID: 32142890
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Murata T
Int J Mol Med; 2015 Jun; 35(6):1773-8. PubMed ID: 25847529
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
Banti I; Nencetti S; Orlandini E; Lapucci A; Breschi MC; Fogli S
J Pharm Pharmacol; 2009 Aug; 61(8):1057-66. PubMed ID: 19703350
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SREBP1 sensitizes cells to death ligands.
Eberhard Y; Gronda M; Hurren R; Datti A; MacLean N; Ketela T; Moffat J; Wrana JL; Schimmer AD
Oncotarget; 2011 Mar; 2(3):186-96. PubMed ID: 21406729
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lipid synthesis by liver X receptor α and sterol regulatory element-binding protein 1 in mammary epithelial cells.
Oppi-Williams C; Suagee JK; Corl BA
J Dairy Sci; 2013 Jan; 96(1):112-21. PubMed ID: 23102957
[TBL] [Abstract][Full Text] [Related]
19. Haloperidol induces demethylation and expression of the dual specificity phosphatase 6 gene in MIA PaCa-2 human pancreatic cancer cells.
Kim SH; Lee HY; Yi H; Ahn YM; Kim YS
Life Sci; 2012 Dec; 91(25-26):1317-22. PubMed ID: 23063941
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer.
Seo JH; Jung KH; Son MK; Yan HH; Ryu YL; Kim J; Lee JK; Hong S; Hong SS
Cancer Lett; 2013 Sep; 338(2):271-81. PubMed ID: 23587795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
